Feasibility of NACT in localized advanced cervical cancer patients Cancer
Conditions
Interventions
The NACT group: FIGO(2009) IB2-IIA2 cervical cancer patients underwent carboplatin-liposomal paclitaxel chemotherapy followed by radical hysterectomy and pelvic lymphadenectomy.
The P
Sponsors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Primary malignant tumor of cervix confirmed by cervical biopsy 2. No other malignant tumors
Exclusion criteria
Exclusion criteria: 1. Cervical metastatic malignant tumor 2. Complicated with other malignant tumors 3. Patients undergoing surgery or pathological examination in other hospitals
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 5-year overall survival defined as the time from completion of operation to death or to the date of last contact. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. 5-year progression-free survival defined as the time from completion of operation to the first appearance of progressive disease or to the date of last contact 2. Cumulative postoperative radiation rate: use of radiation and the interval between surgery and radiation (adjuvant therapy or therapy after recurrence) were used to estimate the cumulative radiation during the follow-up | — |
Countries
China
Outcome results
None listed